CSIMarket Company Name, Ticker, Customers, else..
 
Urogen Pharma Ltd   (NASDAQ: URGN)
 

Urogen Pharma Ltd's Suppliers Performance

URGN's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
URGN Costs vs Sales of Suppliers Growth Urogen Pharma Ltd recorded an increase in cost of sales by 85.13 % year on year, sequentially cost of sales grew by 58.78 % in Q2.

• More on URGN Suppliers



Urogen Pharma Ltd recorded increase in cost of sales by 85.13 % year on year, sequentially cost of sales grew by 58.78 % in Q2.

• More on URGN Suppliers




Urogen Pharma Ltd's Comment on Supply Chain


The company has entered into commercial supply agreements with third-party vendors for Jelmyto and Zusduri. It may also negotiate additional supply agreements for product candidates UGN-103, UGN-104, and UGN-501, or establish backup supply agreements with other third-party manufacturers. Manufacturers involved in current nonclinical and clinical trials comply with current good laboratory practice (cGLP) and current good manufacturing practice (cGMP). The company and its contract manufacturers are responsible for ensuring compliance with FDA and foreign regulatory requirements and conduct extensive audits of vendors, contract laboratories, and suppliers.

Urogen Pharma Ltd's Comment on Supply Chain


The company has entered into commercial supply agreements with third-party vendors for Jelmyto and Zusduri. It may also negotiate additional supply agreements for product candidates UGN-103, UGN-104, and UGN-501, or establish backup supply agreements with other third-party manufacturers. Manufacturers involved in current nonclinical and clinical trials comply with current good laboratory practice (cGLP) and current good manufacturing practice (cGMP). The company and its contract manufacturers are responsible for ensuring compliance with FDA and foreign regulatory requirements and conduct extensive audits of vendors, contract laboratories, and suppliers.







URGN's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Urogen Pharma Ltd 2,083.22 188.32 -97.64 291
SUBTOTAL 0.00 0.00 0.00 -


Sources: Urogen Pharma Ltd 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Urogen Pharma Ltd ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.